Abstract
CorrigendumCORRIGENDUMPublished Online:05 Feb 2019https://doi.org/10.1152/ajpendo.zh1-8043-corr.2019Original articleMoreSectionsPDF (28 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat Kulas JA, Franklin WF, Smith NA, Manocha GD, Puig KL, Nagamoto-Combs K, Hendrix RD, Taglialatela G, Barger SW, Combs CK. Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. Am J Physiol Endocrinol Metab 316: E106–E120, 2019. First published November 13, 2018; doi:10.1152/ajpendo.00279.2018.—In disclosures, the following statement was omitted in error: “S. W. Barger receives royalties from Merck/Sigma-Aldrich for the sales of secreted amyloid precursor protein.”This article has no references to display. Download PDF Previous Back to Top FiguresReferencesRelatedInformation Related ArticlesAblation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues 05 Jan 2019American Journal of Physiology-Endocrinology and Metabolism More from this issue > Volume 316Issue 2February 2019Pages E345-E345 Copyright & PermissionsCopyright © 2019 the American Physiological Societyhttps://doi.org/10.1152/ajpendo.zh1-8043-corr.2019PubMed30721099History Published online 5 February 2019 Published in print 1 February 2019 Metrics
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
